MENDLEIN JOHN
Insider CIK 1238362 · LIFE See Remarks, Director · FATE Director · EDIT Director · OMGA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FATE FATE THERAPEUTICS INC | A Award deriv | 2025-05-29 | 2025-05-30 | 55,000 | — | $0 | 55,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2024-06-07 | 2024-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 18,118 | — | $0 | 18,118 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-06-06 | 2023-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2023-01-19 | 2023-01-20 | 28,461 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2023-01-19 | 2023-01-20 | 28,461 | $1.37 | $39.0K | 311,231 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2023-01-13 | 2023-01-13 | 36,631 | $5.43 | $198.9K | 282,770 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2023-01-11 | 2023-01-13 | 88,048 | $5.67 | $499.2K | 246,139 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 11,893 | — | $0 | 11,893 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-13 | 8,650 | — | $0 | 166,741 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 18,118 | — | $0 | 18,118 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-06-03 | 2022-06-06 | 1,364 | $22.79 | $31.1K | 158,091 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2022-03-10 | 2022-03-11 | 31,562 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-03-10 | 2022-03-11 | 19,493 | $34.73 | $677.0K | 171,524 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-03-10 | 2022-03-11 | 12,069 | $35.48 | $428.2K | 159,455 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2022-03-10 | 2022-03-11 | 31,562 | $1.63 | $51.4K | 191,017 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2021-06-02 | 2021-06-04 | 4,334 | — | $0 | 4,334 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-06-02 | 2021-06-04 | 2,681 | — | $0 | 159,455 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2020-05-01 | 2020-05-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-05-08 | 2019-05-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2019-05-03 | 2019-05-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-12-21 | 2018-12-26 | 195,000 | $0.42 | $81.9K | 615,382 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-12-20 | 2018-12-26 | 50,000 | $0.41 | $20.5K | 420,382 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-05-15 | 2018-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2018-05-02 | 2018-05-04 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-01-02 | 2018-01-02 | 32,000 | — | $0 | 32,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy deriv | 2017-08-31 | 2017-09-05 | 14,151 | — | $0 | 14,151 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2017-08-31 | 2017-09-05 | 37,736 | $2.65 | $100.0K | 367,883 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 11,538 | — | $0 | 11,538 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2017-05-02 | 2017-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2017-04-24 | 2017-04-26 | 124 | $3.00 | $372 | 327,647 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2017-04-20 | 2017-04-20 | 1,552 | $3.00 | $4.7K | 327,523 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2017-04-18 | 2017-04-20 | 1,000 | $3.00 | $3.0K | 325,971 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-02-07 | 2017-02-09 | 185,000 | — | $0 | 185,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-12-19 | 2016-12-21 | 69,000 | $2.20 | $151.8K | 324,971 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2016-05-11 | 2016-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-05 | 2016-04-06 | 2,500 | $3.55 | $8.9K | 248,471 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-05 | 2016-04-07 | 2,500 | $3.52 | $8.8K | 250,971 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2016-02-03 | 2016-02-04 | 96,153 | — | $0 | 96,153 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 135,000 | — | $0 | 135,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-04 | 2016-01-06 | 148,732 | — | $0 | 148,732 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-10-01 | 2015-10-05 | 71,000 | — | $0 | 71,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-10-01 | 2015-10-05 | 65,070 | — | $0 | 65,070 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-05-13 | 2015-05-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 170,218 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 21,122 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 24,055 | — | $0 | 245,971 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-05-06 | 2015-05-08 | 163,437 | — | $0 | 163,437 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2014-06-06 | 2014-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2013-10-04 | 2013-10-07 | 16,667 | $6.00 | $100.0K | 156,774 | SEC↗ |